Atea Pharmaceuticals
AVIR
AVIR
126 hedge funds and large institutions have $406M invested in Atea Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 126 → 126 (0)
12% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 42
Holders
126
Holding in Top 10
1
Calls
$14M
Puts
$935K
Top Buyers
| 1 | +$12.7M | |
| 2 | +$11.4M | |
| 3 | +$10.9M | |
| 4 |
BlackRock
New York
|
+$5.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.2M |
Top Sellers
| 1 | -$9.19M | |
| 2 | -$3.9M | |
| 3 | -$3.56M | |
| 4 |
Two Sigma Investments
New York
|
-$3.49M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3M |